Page 3 - Hookipa Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hookipa biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hookipa Biotech Today - Breaking & Trending Today

HOOKIPA Announces Grant of Inducement Awards Under Nasdaq

NEW YORK and VIENNA, Austria, June 10, 2023 (GLOBE NEWSWIRE) HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of. ....

Reinhard Kandera , Exchange Commission , Pharma Inc , Company Common Stock , Compensation Committee , Common Stock , Nasdaq Listing Rule , Human Papillomavirus , Private Securities Litigation Reform Act , Nasdaq Hook , Hookipa Pharma Inc ,

HOOKIPA Pharma Announces Positive Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab in Patients with HPV16+ Head and Neck Cancers

HB-200 in combination with pembrolizumab doubled the objective response rate of 1st-line pembrolizumab for patients with recurrent/metastatic head and neck cancer HOOKIPA is preparing to start a. | May 31, 2023 ....

United Kingdom , Reinhard Kandera , Joern Aldag , Katia Schlienger , Klaus Orlinger , Drug Administration , Exchange Commission , Pharma Inc , Human Papillomavirus , Chief Executive Officer , Chief Medical Officer , Chief Scientific Officer , Fast Track Designation , Private Securities Litigation Reform Act , Metastatic Head , Neck Squamous Cell Carcinoma , Updated Results , Hookipa Pharma Inc Stock Exchange , Press Release , Tart Hook Us43906k1007 ,

HOOKIPA Pharma Reports First Quarter 2023 Financial Results and Recent Business Highlights

HOOKIPA on track to report Phase 2 data on HB-200 for head and neck cancer in combination with pembrolizumab in 2Q 2023Phase 1 clinical trials initiated for two programs HB-700 for KRAS-mutated. | May 11, 2023 ....

United States , Terry Coelho , Reinhard Kandera , Joern Aldag , Development Expenses , Compensation Committee , Audit Committee , Exchange Commission , Gilead Sciences , American Society Of Clinical Oncology , Pharma Inc , Chief Executive Officer , Clinical Oncology , Annual Meeting , Fast Track , Administrative Expenses , Balance Sheets , Human Papillomavirus , Private Securities Litigation Reform Act , Chief Financial , Hookipa Pharma Inc Stock Exchange , Press Release , Or Hook Us43906k1007 ,

HOOKIPA Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK and VIENNA, Austria, April 14, 2023 HOOKIPA Pharma Inc. , a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the. | April 14, 2023 ....

Matt Beck , Pharma Inc , Company Common Stock , Compensation Committee , Common Stock , Nasdaq Listing Rule , Human Papillomavirus , Hookipa Pharma Inc Stock Exchange , Press Release , Hat Hook Us43906k1007 ,

HOOKIPA Pharma : Reports Second Quarter 2022 Financial Results and Corporate Updates - Form 8-K

HOOKIPA Pharma Reports Second Quarter 2022 Financial Results and Corporate Updates

●

. | August 11, 2022 ....

United States , Matt Beck , Roman Necina , Christined Baker , Katia Schlienger , Joern Aldag , Igor Matushansky , Michael Szumera , Development Officer , American Society Of Clinical Oncology , Drug Administration , Development Expenses , Exchange Commission , Global Head Of Research , American Association For Cancer Research , Pharma Inc , Clinical Development , Reports Second Quarter , New Drug Application , Drug Master File , Chief Executive Officer , Drug Master , American Society , Clinical Oncology , Keystone Symposium , American Association ,